维普中文期刊产品整合服务
25篇 您的检索式:作者名="Chang B U"
    题名 作者 年代 出处 被引量
1The influence of polyvinyl alcohol(PVA)characteristics on the physical stability of encapsulated immobilization media for advanced wastewater treatment显示文摘Chang I S Kim C I Nam B U 2005Process Biochemistry2005,40,9:1
2Differential expression of three 1-deoxy-D-xylulose-5-phosphate synthase genes in rice显示文摘Kim B R Kim S U Chang Y J 2005Biotechnol Lett2005,27,:1
3Automatic identification of wet and dry cough in pediatric pa tients with respiratory diseases 显示文摘SWARNKAR V ABEYRATNE U R CHANG A B 2013Ann Biomed Eng2013,41,5:1
4Evolution of the felinesubgroup parvoviruses and the control of canine host range in Vivo显示文摘Truyen U Gruenberg A Chang S F Obermaier B NVeijalainen P NParrish C R 1995J Virol1995,69,8:1
5Radon exposure assessment for underground workers : a case of Seoul Subway Police officers in Korea显示文摘Song M H Chang B U Kim Y 2011Radiat Prot Dosimetry2011,147,3:1
6Measurement of non-methane hydrocarbons in Taipei city and their impact on ozoneformation in relation to air quality 显示文摘Wu B Z Chang C C Sree U 2006Analytica Chimica Acta2006,576,1:1
7Fiber laser SHG yields broad bandwidth at high power 显示文摘Kang J U Chang Skok Kim Khurgin J B 2002Laser Focus World2002,38,:1
8Active, Population-Based Surveillance for Rotavirus Gastroenteritis in Chinese Children: Beijing Municipality and Gansu Province, China显示文摘Zhang J Liu H Jia L Payne D C Hall A J Xu Z Gao Z Chang Z Jiang B Parashar U D Meng L Yu H Duan Z 2015Pediatr Infect Dis J2015,34,1:1
9Differential expression of three 1- deoxy-D-xylulose-5-phosphate synthase genes in rice 显示文摘Kim B R Kim S U Chang Y J 2005Biotechnol Lett2005,27,:1
10The influence of poly-vinyl-alcohol (PVA) characteristics on the physical stability of encapsulated immobilization media for advanced wastewater treatment显示文摘CHANG I S KIM C NAM B U 0,,9:1
11The influence of poly-vinyl- alcohol (PVA) characteristics on the physical stability of encapsulated immobilization media for advanced wastewater treatment 显示文摘CHANG I S KIM C I NAM B U 2005Process Biochemical2005,40,9:1
12Radon exposure assessment for underground workers : a case of Seoul Subway Police officers in Korea显示文摘SONG M H CHANG B U KIM Y 2011Radiat Prot Dosimetry2011,147,3:1
13Is prophylactic aortic valve replacement with mitral valve repair versus double valve replacement显示文摘HA J W CHOI S U CHANG B E 2003Ann Thorac Surg2003,75,:1
14Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs.Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch 2017World Journal of Virology2017,6,4:1
15Inactivation of Escherichia coli by combining pH,ionic strength and pulsed electric field hurdles显示文摘Vega-Mercado H Pothakamury U R Chang F J BarbosaCanovas G V Swanson B G 1996Food Research International1996,29,:1
16The influence of poly- vinyl-alcohol (PVA) characteristics on the physical stability of encapsulated immobilization media for advanced wastewater treatment 显示文摘CHANG I S KIM C I NAM B U 2005Process Biochemistry2005,40,9:1
17Tauroursodeoxycholic Acid Enhances the Pre‐Implantation Embryo Development by Reducing Apoptosis in Pigs显示文摘J‐S Kim B‐S Song K‐S Lee D‐H Kim S‐U Kim Y‐K Choo K‐T Chang D‐B Koo 2011Reproduction in Domestic Animals2011,,5:1
18Normalization of reverse transcription quantitative-PCR with housekeeping genes in rice 显示文摘Kim B R Nam H Y Kim S U Kim S I Chang Y J 2003Biotechnology Letters2003,25,21:1
19The influence of poly-vinyl-alcohol ( PVA ) characteristics on the physical stability of encapsulated immobilization media for advanced wastewater treatment显示文摘CHANG I S KIM C I NAM B U 2005Process Biochemistry2005,40,:1
20The influence of poly-vinyl-alco- hol (PVA) characteristics on the physical stability of encapsulated immobilization media for advanced wastewater treatment显示文摘Chang I S Kim C I Nam B U 2005Pro- cess Biochemistry2005,40,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费